Filing Details
- Accession Number:
- 0000950170-24-096566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-13 19:55:04
- Reporting Period:
- 2024-08-12
- Accepted Time:
- 2024-08-13 19:55:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 822933343 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1805348 | Paula Hammond | C/O Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco CA 94080 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-08-12 | 10,500 | $5.06 | 60,209 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 10, 2024.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.005 to $5.160. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.